As of January 22, 2025, Genprex (GNPX) has a market cap of $6.398 million USD. According to our data, Genprex is ranked No.8990 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $6.40 M |
-11.74%
|
Dec 31, 2024 | $7.25 M |
-90.74%
|
Dec 29, 2023 | $78.27 M |
-84.14%
|
Dec 30, 2022 | $0.49 B |
10.69%
|
Dec 31, 2021 | $0.45 B |
-68.43%
|
Dec 31, 2020 | $1.41 B |
1,196.87%
|
Dec 31, 2019 | $0.11 B |
-70.91%
|
Dec 31, 2018 | $0.37 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Arbutus Biopharma
ABUS
|
$0.61 B |
-0.000 M
|
USA
|
Arrowhead Pharmaceuticals
ARWR
|
$2.45 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Replimune
REPL
|
$1.00 B |
-0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Vericel
VCEL
|
$2.89 B |
0.000 M
|
USA
|
Market Cap | = | GNPX Stock Price | * | GNPX Shares Outstanding |
= | $0.75 | * | 8.51 M | |
= | $6.40 M |